Some tumor markers were associated with other tumor characteristics at diagnosis, notably FAS, which was overexpressed in ER+ tumors, PR+ tumors, and tumors of lower grade, COX-2, which was overexpressed in HER2− tumors, and CD4, which was overexpressed in tumors without nodal involvement (Table 2). Here, CD4 is linked to neoplasm.